Mitchell Steiner
Chief Executive Officer presso VERU INC.
Patrimonio netto: 4 M $ in data 29/02/2024
Profilo
Founder of GTx, Inc. and Aspen Park Pharmaceuticals, Inc., Mitchell Shuster Steiner presently is Chairman, President & Chief Executive Officer for Veru, Inc. Dr. Steiner is also on the board of The Female Health Company (UK) Plc and Mezzion Pharma Co., Ltd.
Dr. Steiner previously occupied the position of President-Urology at OPKO Health, Inc., Vice Chairman & Chief Executive Officer for GTx, Inc., Vice Chairman, President & Chief Executive Officer at Aspen Park Pharmaceuticals, Inc., Professor at the University of Tennessee and Assistant Professor at Vanderbilt University School of Medicine.
He received an undergraduate degree and a doctorate from Vanderbilt University and a doctorate from the University of Tennessee.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERU INC
5.01% | 16/01/2024 | 7 328 767 ( 5.01% ) | 4 M $ | 29/02/2024 |
Posizioni attive di Mitchell Steiner
Società | Posizione | Inizio |
---|---|---|
VERU INC. | Chief Executive Officer | 31/10/2016 |
MEZZION PHARMA CO.,LTD. | Director/Board Member | - |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Founded in 1989, The Female Health Company (UK) Plc is a subsidiary of Veru, Inc. that manufactures and sells condoms. The private company is based in London, UK. | Director/Board Member | 21/11/2016 |
Precedenti posizioni note di Mitchell Steiner
Società | Posizione | Fine |
---|---|---|
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Founder | 01/10/2016 |
OPKO HEALTH, INC. | Corporate Officer/Principal | 01/01/2016 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Chief Executive Officer | - |
University of Tennessee | Corporate Officer/Principal | 01/01/2004 |
Vanderbilt University School of Medicine | Corporate Officer/Principal | 01/01/1995 |
Formazione di Mitchell Steiner
Vanderbilt University | Doctorate Degree |
University of Tennessee | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
VERU INC. | Health Technology |
OPKO HEALTH, INC. | Health Services |
MEZZION PHARMA CO.,LTD. | Health Technology |
Aziende private | 3 |
---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Distribution Services |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Founded in 1989, The Female Health Company (UK) Plc is a subsidiary of Veru, Inc. that manufactures and sells condoms. The private company is based in London, UK. | Producer Manufacturing |